China Petroleum & Chemical Corporation plans to transfer 4% equity of Sinopec SSC (01033) to Petrochina Group for no consideration.
Sinopec Oilfield Service Corporation (01033) announced that the company received... on September 20, 2024.
SINOPEC SSC (01033) announced that on September 20, 2024, it received a notification from its controlling shareholder, China Petroleum & Chemical Corporation (Petrochina Chemical Group Limited), to deepen the strategic cooperation between China Petroleum & Chemical Corporation and Petrochina Natural Gas Group Limited (Petrochina Group) and to optimize the company's equity structure. On September 20, 2024, China Petroleum & Chemical Corporation and Petrochina Group signed an agreement for the non-compensated transfer, intending to transfer approximately 759 million A shares (about 4.00% of the total share capital of the company, calculated based on the issued share capital of the company as of the date of this announcement) held by China Petroleum & Chemical Corporation to Petrochina Group through the non-compensated transfer of state-owned shares approved by the State-owned Assets Supervision and Administration Commission of the State Council.
Prior to this transfer, China Petroleum & Chemical Corporation directly held 10,727,896,364 A shares of the company, accounting for approximately 56.52% of the company's issued share capital; Petrochina Group did not hold any shares of the company. After this transfer, China Petroleum & Chemical Corporation will directly hold 9,968,726,364 A shares of the company, accounting for approximately 52.52% of the company's issued share capital, while Petrochina Group will directly hold 759,170,000 A shares, accounting for approximately 4.00% of the company's issued share capital. This transfer will not result in any changes to the company's controlling shareholders or ultimate controlling parties.
Related Articles

CK LIFE SCIENCES(00775): Positive results achieved in the mid-term analysis of the Phase IIb study of Halneuron in treating chemotherapy-induced neuropathic pain.

Bitcoin winter is coming? Whale Strategy (MSTR.US) pauses buying spree, hoarding $2.2 billion in cash to prepare for winter.

Shanghai Fosun Pharmaceutical (02196) responds to the acquisition of LvGu Pharmaceutical: The confirmatory clinical research on mannitol sodium capsules has been recognized by the Drug Evaluation Center, with a total of 580 cases enrolled.
CK LIFE SCIENCES(00775): Positive results achieved in the mid-term analysis of the Phase IIb study of Halneuron in treating chemotherapy-induced neuropathic pain.

Bitcoin winter is coming? Whale Strategy (MSTR.US) pauses buying spree, hoarding $2.2 billion in cash to prepare for winter.

Shanghai Fosun Pharmaceutical (02196) responds to the acquisition of LvGu Pharmaceutical: The confirmatory clinical research on mannitol sodium capsules has been recognized by the Drug Evaluation Center, with a total of 580 cases enrolled.






